|
Press Releases |
|
|
|
Tuesday, May 30, 2023 |
|
Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients |
Avance Clinical, the leading award-winning Australian and North American CRO that offers ClinicReady and GlobalReady for early phase biotech companies to speed up the path to regulatory approval, says early phase oncology studies are increasingly more complex and demand more patients. more info >> |
|
Thursday, May 25, 2023 |
|
아방스 임상, 인생을 변화시키고 생명을 구하는 치료법에 대한 신속한 접근을 위해 글로벌 보건 정상회의 캠페인에 합류 |
초기 단계 생명 공학 회사들에 규제 승인 속도를 높이기 위한 ClinicReady 및 GlobalReady 프로그램을 제공하는 수상 경력이 빛나는 선도적인 호주 및 북미 생명 공학 CRO인 아방스 임상(Avance Clinical)은 로이터 통신에 소개될 글로벌 보건 정상회의 캠페인에 초대되었습니다. more info >> |
|
Avance Clinical 加入全球健康峰會活動,以更快獲得改變生活和拯救生命的療法 |
Avance Clinical 是領先的屢獲殊榮的澳大利亞和北美生物技術 CRO,為早期生物技術公司提供 ClinicReady 和 GlobalReady 計劃以加快獲得監管批准的路徑,已受邀參加路透社報導的全球健康峰會活動。 more info >> |
|
Avance Clinical 加入全球健康峰会活动,以更快获得改变生活和拯救生命的疗法 |
Avance Clinical 是领先的屡获殊荣的澳大利亚和北美生物技术 CRO,为早期生物技术公司提供 ClinicReady 和 GlobalReady 计划以加快获得监管批准的路径,已受邀参加路透社报道的全球健康峰会活动。 more info >> |
|
Avance Clinical Joins Global Health Summit Campaign for Faster Access to Life-Changing and Life-Saving Therapies |
Avance Clinical the leading award-winning Australian and North American CRO that offers the programs ClinicReady and GlobalReady for early phase biotech companies to speed up the path to regulatory approval, has been invited to join the Global Health Summit campaign which will be featured on Reuters. more info >> |
|
Tuesday, April 18, 2023 |
|
Avance Clinical 首席執行官加入 2023 年歐洲進化峰會 全球生物製藥小組 |
Avance Clinical是領先的屢獲殊榮的澳大利亞和北美生物技術 CRO,為早期生物技術公司提供 GlobalReady 計劃以加快獲得監管批准的路徑,已受邀參加 2023 年歐洲進化峰會( 2023 年 4 月 20 日至 21 日,瑞士蒙特勒)。小組討論的重點是臨床試驗的發展,包括技術、DCT、減少時間和成本、批准的藥物開發計劃以及後期階段的全球擴展。 more info >> |
|
Avance Clinical 首席执行官加入 2023 年欧洲进化峰会 全球生物制药小组 |
Avance Clinical是领先的屡获殊荣的澳大利亚和北美生物技术 CRO,为早期生物技术公司提供 GlobalReady 计划以加快获得监管批准的路径,已受邀参加 2023 年欧洲进化峰会( 2023 年 4 月 20 日至 21 日,瑞士蒙特勒)。小组讨论的重点是临床试验的发展,包括技术、DCT、减少时间和成本、批准的药物开发计划以及后期阶段的全球扩展。 more info >> |
|
아방스 임상 CEO, 에볼루션 유럽 서밋 2023의 글로벌 바이오파마 패널에 참가 |
초기 단계 생명 공학 회사들에 규제 승인 속도를 높이기 위한 GlobalReady 프로그램을 제공하는 수상 경력이 빛나는 선도적인 호주 및 북미 생명 공학 CRO인 아방스 임상(Avance Clinical)이 에볼루션 유럽 서밋 2023(스위스 몽트뢰, 2023년 4월 20일 - 4월 21일)에 초대되었습니다. 패널 토론은 기술, DCT, 시간 및 비용 절감, 승인을 위한 약물 개발 계획, 이후 단계의 글로벌 확장을 포함한 임상 시험의 발전에 중점을 두고 진행됩니다. more info >> |
|
アバンセ・クリニカルのCEOが2023年エボリューション・ヨーロッパ・サミットのグローバル・バイオファーマ・パネルに参加 |
受賞歴のあるオーストラリアおよび北米の大手バイオテクノロジーCROであり、規制当局の承認への道を迅速化するために、初期段階のバイオテクノロジー企業にGlobalReadyプログラムを提供するアバンセ・クリニカルは、このたび、Evolution Europe Summit 2023(スイス・モントルー、2023年4月20日・21日開催)に招待されました。 more info >> |
|
Avance Clinical CEO Joins Global BioPharma Panel for Evolution Europe Summit 2023 |
Avance Clinical the leading award-winning Australian and North American biotech CRO that offers a GlobalReady program to early phase biotech companies to speed up the path to regulatory approval, has been invited to join the Evolution Europe Summit 2023 (Montreux, Switzerland 20 April - 21 April 2023). more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
侨雄国际宣布委任段玉聪院士为人工智能实验室首席科学家
Nov 5, 2024 19:25 HKT/SGT
|
|
|
华邦科技正式更名为「亨利加集团有限公司」
Nov 5, 2024 19:15 HKT/SGT
|
|
|
華邦科技正式更名為「亨利加集團有限公司」
Nov 5, 2024 19:11 HKT/SGT
|
|
|
僑雄國際宣佈委任段玉聰院士為人工智能實驗室首席科學家
Nov 5, 2024 19:00 HKT/SGT
|
|
|
ALMAC to open mid-November
Nov 5, 2024 18:46 HKT/SGT
|
|
|
Champion REIT Recognised as 'GRESB Global Listed Sector Leader'
Nov 5, 2024 18:11 HKT/SGT
|
|
|
富士通、東証の株式売買システム「arrowhead4.0」を運用開始
Nov 5, 2024 18:00: JST
|
|
|
冠君产业信托获GRESB评为「全球业界领导者(上市企业)」
Nov 5, 2024 17:41 HKT/SGT
|
|
|
冠君產業信託獲GRESB評為「全球業界領導者(上市企業)」
Nov 5, 2024 17:14 HKT/SGT
|
|
|
Victory and world title for TOYOTA GAZOO Racing
Nov 5, 2024 17:59 JST
|
|
|
Tokyo Stock Exchange and Fujitsu announce renewal of cash equity trading system 'arrowhead4.0'
Nov 5, 2024 17:13 JST
|
|
|
Mitsubishi Heavy Industries Continues Order Intake, Revenue, and Profit Growth in Strong First Half, Raises Full-Year Order Intake Guidance
Nov 5, 2024 14:37 JST
|
|
|
Interroyal Engineering PCL (SET: IROYAL) Posts Strong Showing on First Trading Day
Nov 5, 2024 13:00 HKT/SGT
|
|
|
華泰證券入圍「跨境理財通」試點 服務大灣區多元化財富管理需求
Nov 5, 2024 11:50 HKT/SGT
|
|
|
Eisai's Corporate Venture Capital Subsidiary, Eisai Innovation, Inc., Selected for AMED's 'Strengthening Program for Pharmaceutical Startup Ecosystem"
Nov 5, 2024 11:35 JST
|
|
|
|
More News >> |
|
|
|
|
|